Net Debt Summary of Amgen Inc.

Amgen Inc.'s latest annual net debt in 2023 was 53.66 Billion USD , up 71.38% from previous year.
Amgen Inc.'s latest quarterly net debt in 2024 Q2 was 53.34 Billion USD , down -1.78% from previous quarter.
Amgen Inc. reported annual net debt of 31.31 Billion USD in 2022, up 23.68% from previous year.
Amgen Inc. reported annual net debt of 25.32 Billion USD in 2021, down -5.24% from previous year.
Amgen Inc. reported quarterly net debt of 53.34 Billion USD for 2024 Q2, down -1.78% from previous quarter.
Amgen Inc. reported quarterly net debt of 51.38 Billion USD for 2024 Q3, down -3.67% from previous quarter.

Annual Net Debt Chart of Amgen Inc. (2023 - 1990)

Historical Annual Net Debt of Amgen Inc. (2023 - 1990)

Year	Net Debt	Net Debt Growth
2023	53.66 Billion USD	71.38%
2022	31.31 Billion USD	23.68%
2021	25.32 Billion USD	-5.24%
2020	26.72 Billion USD	11.96%
2019	23.86 Billion USD	-11.55%
2018	26.98 Billion USD	-14.45%
2017	31.54 Billion USD	0.6%
2016	31.35 Billion USD	14.38%
2015	27.41 Billion USD	1.59%
2014	26.98 Billion USD	-4.73%
2013	28.32 Billion USD	21.7%
2012	23.27 Billion USD	60.7%
2011	14.48 Billion USD	43.74%
2010	10.07 Billion USD	30.56%
2009	7.71 Billion USD	-8.15%
2008	8.4 Billion USD	-8.2%
2007	9.15 Billion USD	18.42%
2006	7.72 Billion USD	265.09%
2005	2.11 Billion USD	-40.93%
2004	3.58 Billion USD	59.79%
2003	2.24 Billion USD	70.06%
2002	1.31 Billion USD	460.16%
2001	-366.2 Million USD	-480.67%
2000	96.2 Million USD	-49.79%
1999	191.6 Million USD	50.16%
1998	127.6 Million USD	541.21%
1997	19.9 Million USD	151.9%
1996	7.9 Million USD	-95.62%
1995	180.2 Million USD	150.97%
1994	71.8 Million USD	-55.82%
1993	162.5 Million USD	307.27%
1992	39.9 Million USD	138.0%
1991	-105 Million USD	-483.21%
1990	27.4 Million USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	54.31 Billion USD	1.2%
2024 Q2	53.34 Billion USD	-1.78%
2024 Q3	51.38 Billion USD	-3.67%
2023 Q1	30.03 Billion USD	-4.09%
2023 FY	53.66 Billion USD	71.38%
2023 Q4	53.66 Billion USD	108.61%
2023 Q3	25.72 Billion USD	-5.75%
2023 Q2	27.29 Billion USD	-9.12%
2022 Q2	31.31 Billion USD	3.27%
2022 Q4	31.31 Billion USD	7.24%
2022 FY	31.31 Billion USD	23.68%
2022 Q1	30.32 Billion USD	19.77%
2022 Q3	29.2 Billion USD	-6.76%
2021 Q4	25.32 Billion USD	-1.13%
2021 Q1	26.57 Billion USD	-0.55%
2021 Q2	26.15 Billion USD	-1.58%
2021 FY	25.32 Billion USD	-5.24%
2021 Q3	25.61 Billion USD	-2.07%
2020 Q2	25.07 Billion USD	3.8%
2020 Q4	26.72 Billion USD	6.03%
2020 Q3	25.2 Billion USD	0.48%
2020 FY	26.72 Billion USD	11.96%
2020 Q1	24.16 Billion USD	1.24%
2019 Q4	23.86 Billion USD	29.88%
2019 Q2	25.08 Billion USD	-2.25%
2019 Q3	18.37 Billion USD	-26.76%
2019 Q1	25.66 Billion USD	-4.88%
2019 FY	23.86 Billion USD	-11.55%
2018 Q2	24.36 Billion USD	-5.56%
2018 FY	26.98 Billion USD	-14.45%
2018 Q4	26.98 Billion USD	20.08%
2018 Q3	22.47 Billion USD	-7.78%
2018 Q1	25.8 Billion USD	-18.2%
2017 Q4	31.54 Billion USD	-3.76%
2017 FY	31.54 Billion USD	0.6%
2017 Q1	30.73 Billion USD	-1.98%
2017 Q2	32.43 Billion USD	5.53%
2017 Q3	32.77 Billion USD	1.06%
2016 Q3	31.83 Billion USD	4.07%
2016 Q2	30.59 Billion USD	-2.61%
2016 Q4	31.35 Billion USD	-1.52%
2016 FY	31.35 Billion USD	14.38%
2016 Q1	31.41 Billion USD	14.59%
2015 Q2	28.15 Billion USD	2.47%
2015 Q4	27.41 Billion USD	-3.94%
2015 Q3	28.53 Billion USD	1.34%
2015 Q1	27.47 Billion USD	1.83%
2015 FY	27.41 Billion USD	1.59%
2014 Q2	28.97 Billion USD	2.26%
2014 Q1	28.33 Billion USD	0.05%
2014 FY	26.98 Billion USD	-4.73%
2014 Q4	26.98 Billion USD	-7.91%
2014 Q3	29.3 Billion USD	1.13%
2013 Q4	28.32 Billion USD	49.79%
2013 Q3	18.9 Billion USD	4.41%
2013 Q2	18.1 Billion USD	-15.23%
2013 Q1	21.36 Billion USD	-8.21%
2013 FY	28.32 Billion USD	21.7%
2012 Q3	20.65 Billion USD	11.47%
2012 Q1	17.2 Billion USD	18.78%
2012 Q2	18.52 Billion USD	7.71%
2012 FY	23.27 Billion USD	60.7%
2012 Q4	23.27 Billion USD	12.67%
2011 Q1	9.64 Billion USD	-4.31%
2011 FY	14.48 Billion USD	43.74%
2011 Q4	14.48 Billion USD	39.6%
2011 Q3	10.37 Billion USD	30.79%
2011 Q2	7.93 Billion USD	-17.73%
2010 Q1	7.02 Billion USD	-9.03%
2010 FY	10.07 Billion USD	30.56%
2010 Q2	10.02 Billion USD	42.74%
2010 Q4	10.07 Billion USD	-2.57%
2010 Q3	10.34 Billion USD	3.2%
2009 Q2	8.5 Billion USD	-1.48%
2009 FY	7.71 Billion USD	-8.15%
2009 Q4	7.71 Billion USD	-3.04%
2009 Q1	8.63 Billion USD	2.73%
2009 Q3	7.95 Billion USD	-6.4%
2008 Q1	6.85 Billion USD	-25.13%
2008 Q2	7.78 Billion USD	13.57%
2008 FY	8.4 Billion USD	-8.2%
2008 Q3	8.65 Billion USD	11.19%
2008 Q4	8.4 Billion USD	-2.91%
2007 Q3	9.92 Billion USD	3.54%
2007 Q2	9.58 Billion USD	53.43%
2007 FY	9.15 Billion USD	18.42%
2007 Q1	6.24 Billion USD	-19.17%
2007 Q4	9.15 Billion USD	-7.77%
2006 Q1	7.21 Billion USD	240.77%
2006 Q4	7.72 Billion USD	0.18%
2006 FY	7.72 Billion USD	265.09%
2006 Q2	7.05 Billion USD	-2.23%
2006 Q3	7.71 Billion USD	9.39%
2005 Q3	1.8 Billion USD	-22.57%
2005 Q4	2.11 Billion USD	17.55%
2005 FY	2.11 Billion USD	-40.93%
2005 Q1	2.75 Billion USD	-23.02%
2005 Q2	2.32 Billion USD	-15.69%
2004 Q2	1.37 Billion USD	-40.72%
2004 Q1	2.32 Billion USD	3.71%
2004 FY	3.58 Billion USD	59.79%
2004 Q4	3.58 Billion USD	69.22%
2004 Q3	2.11 Billion USD	53.61%
2003 Q4	2.24 Billion USD	10.92%
2003 FY	2.24 Billion USD	70.06%
2003 Q3	2.02 Billion USD	0.29%
2003 Q2	2.01 Billion USD	173.01%
2003 Q1	738.5 Million USD	-44.01%
2002 Q3	2 Billion USD	1237.78%
2002 Q1	165.6 Million USD	145.22%
2002 Q2	149.8 Million USD	-9.54%
2002 Q4	1.31 Billion USD	-34.19%
2002 FY	1.31 Billion USD	460.16%
2001 Q4	-366.2 Million USD	-1038.97%
2001 Q1	-156.7 Million USD	-262.89%
2001 Q2	40.4 Million USD	125.78%
2001 Q3	39 Million USD	-3.47%
2001 FY	-366.2 Million USD	-480.67%
2000 Q2	186.5 Million USD	-5.33%
2000 Q4	96.2 Million USD	-40.76%
2000 Q3	162.4 Million USD	-12.92%
2000 Q1	197 Million USD	2.82%
2000 FY	96.2 Million USD	-49.79%
1999 Q1	208.8 Million USD	63.64%
1999 Q2	23.4 Million USD	-88.79%
1999 Q3	134.4 Million USD	474.36%
1999 FY	191.6 Million USD	50.16%
1999 Q4	191.6 Million USD	42.56%
1998 Q2	175.5 Million USD	13.67%
1998 FY	127.6 Million USD	541.21%
1998 Q1	154.4 Million USD	675.88%
1998 Q3	224.5 Million USD	27.92%
1998 Q4	127.6 Million USD	-43.16%
1997 Q2	-132 Million USD	20.39%
1997 Q3	-80.9 Million USD	38.71%
1997 FY	19.9 Million USD	151.9%
1997 Q1	-165.8 Million USD	-2198.73%
1997 Q4	19.9 Million USD	124.6%
1996 FY	7.9 Million USD	-95.62%
1996 Q1	114.8 Million USD	-36.29%
1996 Q4	7.9 Million USD	115.86%
1996 Q3	-49.8 Million USD	-34.59%
1996 Q2	-37 Million USD	-132.23%
1995 Q4	180.2 Million USD	36.83%
1995 Q3	131.7 Million USD	54.22%
1995 Q2	85.4 Million USD	4.79%
1995 Q1	81.5 Million USD	13.51%
1995 FY	180.2 Million USD	150.97%
1994 Q2	34 Million USD	-74.91%
1994 FY	71.8 Million USD	-55.82%
1994 Q1	135.5 Million USD	-16.62%
1994 Q4	71.8 Million USD	548.75%
1994 Q3	-16 Million USD	-147.06%
1993 Q1	109.4 Million USD	174.19%
1993 Q3	100.3 Million USD	66.61%
1993 Q4	162.5 Million USD	62.01%
1993 FY	162.5 Million USD	307.27%
1993 Q2	60.2 Million USD	-44.97%
1992 Q3	66.1 Million USD	148.5%
1992 FY	39.9 Million USD	138.0%
1992 Q4	39.9 Million USD	-39.64%
1992 Q2	26.6 Million USD	165.84%
1992 Q1	-40.4 Million USD	61.52%
1991 Q4	-105 Million USD	-12.42%
1991 Q1	-21.2 Million USD	-318.56%
1991 Q3	-93.4 Million USD	-46.86%
1991 Q2	-63.6 Million USD	-200.0%
1991 FY	-105 Million USD	-483.21%
1990 FY	27.4 Million USD	0.0%
1990 Q1	27.4 Million USD	-37.44%
1990 Q2	-15.9 Million USD	-158.03%
1990 Q4	9.7 Million USD	136.19%
1990 Q3	-26.8 Million USD	-68.55%
1989 Q2	2 Million USD	-82.61%
1989 Q3	54.2 Million USD	2610.0%
1989 Q4	43.8 Million USD	-19.19%
1989 Q1	11.5 Million USD	0.0%

Peer Net Debt Comparison of Amgen Inc.

Name	Net Debt	Net Debt Difference
AstraZeneca PLC	22.78 Billion USD	-135.576%
Biogen Inc.	6.28 Billion USD	-753.474%
Gilead Sciences, Inc.	18.9 Billion USD	-183.933%
MIRA Pharmaceuticals, Inc.	-4.59 Million USD	1167450.552%
Scilex Holding Company	124.54 Million USD	-42993.093%
Scilex Holding Company	124.54 Million USD	-42993.093%

Global Stocks Search

Amgen Inc. (AMGN)

Net Debt Summary of Amgen Inc.

Annual Net Debt Chart of Amgen Inc. (2023 - 1990)

Historical Annual Net Debt of Amgen Inc. (2023 - 1990)

Peer Net Debt Comparison of Amgen Inc.